de Waard-Siebinga I, Kool J, Jager M J
Department of Ophthalmology, University Hospital Leiden, The Netherlands.
Hum Immunol. 1995 Oct;44(2):111-7. doi: 10.1016/0198-8859(95)00083-g.
Immunotherapy with cytokines may be an additional option in the treatment of primary uveal melanoma or melanoma metastases. A study of the effect of cytokines on cultured uveal melanoma cells may predict the effect that cytokines may have in vivo. Knowledge about the influence of cytokines on HLA expression may be especially beneficial, as HLA expression is essential for immune recognition. However, little is known about the normal expression of the HLA antigens on uveal melanoma cells in tissue culture. We therefore determined the HLA expression on short-term cultures of uveal melanoma cells and compared the results to the expression on tissue sections of the original tumors. In vivo and in vitro expression of the monomorphic HLA class I determinants and of HLA-A (R = 0.77) correlated well. A slightly lower agreement was observed for expression of HLA-B (R = 0.68). In vitro growth was associated with a decrease in expression of the class II determinant HLA-DR. We conclude that expression of HLA class I on cultured melanoma cells corresponds to the expression on the original tumor, allowing the applicability of cultured cells as predictors of responsiveness to cytokines in vivo.
细胞因子免疫疗法可能是原发性葡萄膜黑色素瘤或黑色素瘤转移灶治疗的另一种选择。一项关于细胞因子对培养的葡萄膜黑色素瘤细胞作用的研究可能会预测细胞因子在体内可能产生的效果。了解细胞因子对HLA表达的影响可能特别有益,因为HLA表达对于免疫识别至关重要。然而,关于组织培养中葡萄膜黑色素瘤细胞上HLA抗原的正常表达情况知之甚少。因此,我们测定了葡萄膜黑色素瘤细胞短期培养物上的HLA表达,并将结果与原始肿瘤组织切片上的表达进行了比较。单态性HLA I类决定簇和HLA-A的体内和体外表达相关性良好(R = 0.77)。观察到HLA-B表达的一致性略低(R = 0.68)。体外生长与II类决定簇HLA-DR表达的降低有关。我们得出结论,培养的黑色素瘤细胞上HLA I类的表达与原始肿瘤上的表达相对应,这使得培养的细胞可作为体内对细胞因子反应性的预测指标。